TOMI Environmental Solutions, announces substantial progress in its custom integration pipeline, currently valued at approximately $3 million, signaling significant momentum in the life sciences sector.
Leveraging Capital Rx’s spread-free, full pass-through pharmacy benefit model, Capital Equilibrium is bringing Rx cost savings and renewal stability to the self-funded municipality and commercial
GE HealthCare has received FDA Premarket Authorization for Pristina Recon DL, an innovative 3D mammography reconstruction application. GE HealthCare that it has received FDA Premarket
Healthcare organizations nationwide are increasingly viewing clinical education as a critical investment in preparing the rehabilitation workforce for the future. Exxat has announced that Continuum
PDS Health Technologies, a business unit of PDS Health, has announced a strategic partnership with the University of Michigan School of Dentistry to implement a
SEI, a prominent employee-owned consulting firm, has appointed Patrick Donegan as Managing Director of its Philadelphia office. In this expanded role, Patrick will also continue
Prestige Biopharma, a biopharmaceutical company focused on antibody therapeutics, announced an exclusive license and supply agreement with Biosidus, a biotechnology company based in Buenos Aires,
Renalys Pharma, Inc., headquartered in Chuo-ku, Tokyo, has announced encouraging topline results from its Phase III clinical trial of sparsentan, an orally administered dual endothelin
Sectra, a global medical imaging IT and cybersecurity company, is introducing its integrated reporting solution, Sectra Reporting, to the United States market. The solution unifies
Restore Medical Ltd., a privately held medical device company developing an innovative transcatheter therapy for heart failure, announced the appointment of Chris Cleary, former Senior
In the STEP UP phase 3 trial, adults with obesity taking semaglutide 7.2 mg as directed lost an average of 20.7% body weight Novo Nordisk
Zydus Lifesciences Ltd., along with its subsidiaries and affiliates, a global healthcare company focused on innovation, has announced an exclusive licensing and commercialization agreement with
